Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Flavivirus pathogenesis

Zika immune imprint risks dengue

Previous Zika virus infection results in the production of anti-NS1 IgA antibodies that complex with soluble NS1 from subsequent dengue virus infection to activate neutrophils, which release pro-inflammatory mediators to exacerbate the risk of severe dengue.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Immune imprinting from ZIKV infection risks severe dengue.

References

  1. Messina, J. P. et al. Nat Microbiol 4, 1508–1515 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Cardona-Ospina, J. A. et al. Nat. Immunol. https://doi.org/10.1038/s41590-025-02363-9 (2026).

    Article  Google Scholar 

  3. Kalimuddin, S., Chia, P. Y., Low, J. G. & Ooi, E. E. Clin. Microbiol. Rev. https://doi.org/10.1128/cmr.00244-24 (2025).

    Article  PubMed  Google Scholar 

  4. Zambrana, J. V. et al. Sci. Transl. Med. 16, eadn2199 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wegman, A. D. et al. Front. Immunol. 12, 777672 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Cerutti, A. Nat. Rev. Immunol. 8, 421–434 (2008).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Campbell, V. L. et al. Immunohorizons 4, 444–453 (2020).

    Article  PubMed  CAS  Google Scholar 

  8. Deng, Z. et al. Signal Transduct. Target Ther. 9, 61 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Chen, W. Annu Rev. Immunol. 41, 483–512 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gonnella, G. et al. Cell Host Microbe 33, 1191–1207.e1194 (2025).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Kalimuddin, S. & Ooi, E. E. Cell Host Microbe 33, 1050–1051 (2025).

    Article  PubMed  CAS  Google Scholar 

  12. Trunfio, M., Savoldi, A., Vigano, O. & d’Arminio Monforte, A. Infection 45, 1–10 (2017).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eng Eong Ooi.

Ethics declarations

Competing interests

E.E.O. has served in advisory capacities on dengue to Sanofi Pasteur, Takeda Pharmaceuticals, MSD (Merck), Johnson and Johnson and Novartis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ooi, E.E. Zika immune imprint risks dengue. Nat Immunol 27, 10–11 (2026). https://doi.org/10.1038/s41590-025-02365-7

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41590-025-02365-7

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing